10 completed, 6 terminated, 4 active not recruiting, 4 unknown. 9 Phase 2, 3 Phase 1, 2 Phase 3, 1 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 9 | Completed 5, Terminated 3, Recruiting 1 |
| Phase 1 | 3 | Completed 2, Active not recruiting 1 |
| Phase 3 | 2 | Terminated 2 |
| Early Phase 1 | 1 | Active not recruiting 1 |
Follow Idiopathic Interstitial Pneumonias: new trials by email Literature Review of Idiopathic Interstitial Pneumonias trials Research Report on Idiopathic Interstitial Pneumonias
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Zinc and Nicotinamide Riboside for Idiopathic Pulmonary Fibrosis Zinc, Placebos for zinc and nicotinamide riboside, Nicotinamide riboside - Idiopathic Pulmonary Fibrosis | Phase 2 | Recruiting | Cedars-Sinai Medical Center | 60 | 2025-11-03 | 2025-11-10 |
| Deep Learning Diagnostic and Risk-stratification for IPF and COPD Lung auscultation, Lung ultrasound, Quality of Life's questionnaires - Lung; Disease, Interstitial, With Fibrosis, Pulmonary Disease, Chronic Obstructive | Unknown | Pediatric Clinical Research Platform | 160 | 2023-04-01 | 2024-04-12 | |
| Atezolizumab for Idiopathic Pulmonary Fibrosis Atezolizumab - Idiopathic Pulmonary Fibrosis | Phase 1 | Active not recruiting | Cedars-Sinai Medical Center | 24 | 2023-02-15 | 2026-02-20 |
| Interstitial Lung Disease: A Study From Infancy to Elderly Including Relatives Interstitial Lung Diseases | Recruiting | Institut National de la Santé Et de la Recherche Médicale, France | 3000 | 2022-01-19 | 2026-02-12 | |
| FAPI PET for Lung Fibrosis 68Ga-FAPi-46, Computed Tomography, Positron Emission Tomography - Interstitial Lung Disease, Idiopathic Interstitial Pneumonias | Early Phase 1 | Active not recruiting | University of California, Los Angeles | 30 | 2021-11-16 | 2026-08-20 |
| Precision Diagnosis and Care for Families With Pulmonary Fibrosis in Ireland Six minute walk test (6MWT), Computer-tomography of the thorax (CT Thorax), Quality of life questionnaires. - Connective Tissue Diseases, Interstitial Lung Disease | Recruiting | Royal College of Surgeons, Ireland | 300 | 2021-09-28 | 2024-11-22 | |
| The Safety, Tolerability, and Pharmacokinetic Study of SC1011 in Healthy Subjects. SC1011 - Diopathic Pulmonary Fibrosis, Pulmonary Fibrosis | Phase 1 | Completed | Guangzhou JOYO Pharma Co., Ltd | 55 | 2021-06-03 | 2024-11-19 |
| Zephyrus II: Efficacy and Safety Study of Pamrevlumab in Participants With Idiopathic Pulmonary Fibrosis (IPF) Pamrevlumab, Placebo - Idiopathic Pulmonary Fibrosis | Phase 3 | Terminated | Kyntra Bio | 372 | 2020-09-30 | 2024-08-12 |
| Screening Microorganism of Cryptogenic Mechanical Pneumonia Through Next Generation Sequencing to Lung Tissue Fluid Next-generation sequencing - Cryptogenic Organizing Pneumonia, Idiopathic Interstitial Pneumonias | Unknown | Shanghai Pulmonary Hospital, Shanghai, China | 100 | 2020-08-07 | 2020-09-01 | |
| A Study Measuring the Effectiveness, Safety, and Tolerability of BMS-986278 in Participants With Lung Fibrosis BMS-986278 Placebo, BMS-986278 - Pulmonary Fibrosis | Phase 2 | Completed | Bristol-Myers Squibb | 403 | 2020-07-29 | 2026-02-03 |
| Interstitial Pneumonia With Autoimmune Features: Evaluation of Connective Tissue Disease Incidence During Follow-up Follow-up - Idiopathic Interstitial Pneumonia | Unknown | Central Hospital, Nancy, France | 300 | 2020-03-01 | 2019-11-26 | |
| The Relationship Between Hormone Sensitivity and Imaging of Idiopathic Interstitial Pneumonia by Artificial Intelligence high resolution CT - Idiopathic Interstitial Pneumonia | Completed | Peking University Third Hospital | 150 | 2019-12-30 | 2021-12-07 | |
| Molecular Diagnosis of Idiopathic Interstitial Pneumonias: a Prospective Study Microarray analysis - Idiopathic Interstitial Pneumonia, Idiopathic Pulmonary Fibrosis | Completed | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | 55 | 2019-06-28 | 2025-03-11 | |
| Zephyrus I: Evaluation of Efficacy and Safety of Pamrevlumab in Participants With Idiopathic Pulmonary Fibrosis (IPF) Pamrevlumab, Placebo - Idiopathic Pulmonary Fibrosis | Phase 3 | Terminated | Kyntra Bio | 393 | 2019-06-18 | 2024-09-19 |
| BPF Genetics of ILD Study Genetic profiling - Lung; Disease, Interstitial, With Fibrosis, Alveolitis, Extrinsic Allergic | Completed | University of Dundee | 475 | 2019-01-19 | 2026-05-27 | |
| University of Virginia Natural History Study Interstitial Lung Disease - Interstitial Lung Disease, Idiopathic Pulmonary Fibrosis | Enrolling by invitation | University of Virginia | 2500 | 2018-08-28 | 2024-05-08 | |
| A Study to Evaluate the Efficacy and Safety of CC-90001 in Subjects With Idiopathic Pulmonary Fibrosis CC-90001, Placebo - Idiopathic Pulmonary Fibrosis, Fibrosis | Phase 2 | Terminated | Celgene | 138 | 2017-07-26 | 2023-06-28 |
| Japanese Idiopathic Interstitial Pneumonias Registry Idiopathic Interstitial Pneumonia | Active not recruiting | North East Japan Study Group | 867 | 2016-12-01 | 2026-02-05 | |
| A 2-Part, Phase 2 Open-label and Crossover Study of Belumosudil for Treatment of Idiopathic Pulmonary Fibrosis Belumosudil, BSC - Idiopathic Pulmonary Fibrosis | Phase 2 | Completed | Kadmon Corporation, LLC | 76 | 2016-05-26 | 2022-09-08 |
| Efficacy and Safety of Riociguat in Patients With Symptomatic Pulmonary Hypertension (PH) Associated With Idiopathic Interstitial Pneumonias (IIP) Riociguat (Adempas, BAY63-2521), Placebo - Idiopathic Interstitial Pneumonias / Hypertension,Pulmonary | Phase 2 | Terminated | Bayer | 147 | 2014-06-04 | 2017-12-04 |
Showing 20 of 28. Sign in to see all of them.
Idiopathic Pulmonary Fibrosis (20) · Lung Diseases, Interstitial (15) · Pulmonary Fibrosis (12) · Alveolitis, Extrinsic Allergic (3) · Connective Tissue Diseases (3) · Cryptogenic Organizing Pneumonia (3) · Disease (3) · Lung Diseases (3) · Fibrosis (2) · Pulmonary Disease, Chronic Obstructive (2) · Respiratory Tract Diseases (2) · Sarcoidosis (2) · Bird Fancier's Lung (1) · Bronchiolitis Obliterans (1)
Respiratory Tract Diseases (26) · Lung Diseases (25) · Pulmonary Fibrosis (16) · Pathological Conditions, Signs and Symptoms (15) · Pathologic Processes (14) · Lung Diseases, Interstitial (13) · Fibrosis (10) · Idiopathic Pulmonary Fibrosis (8) · Hypersensitivity (4) · Immune System Diseases (4) · Lung Diseases, Obstructive (4) · Bronchial Diseases (3) · Bronchiolitis (3) · Bronchitis (3) · Hypersensitivity, Immediate (3)
pamrevlumab (3) · Azithromycin (1) · Budesonide (1) · Budesonide, Formoterol Fumarate Drug Combination (1) · CC-90001 (1) · FAPI-46 (1) · Formoterol Fumarate (1) · Genetic Testing (1) · Immunoglobulin G (1) · KD025 (1) · Magnetic Resonance Spectroscopy (1) · ORF 50 transactivator (1) · Observation (1) · Prednisone (1) · Spirometry (1)
Kyntra Bio (3) · Cedars-Sinai Medical Center (2) · Andreas Guenther (1) · Bayer (1) · Biogen (1) · Bristol-Myers Squibb (1) · Celgene (1) · Central Hospital, Nancy, France (1) · Duke University (1) · Federal Research Clinical Center of Federal Medical & Biological Agency, Russia (1) · Guangzhou JOYO Pharma Co., Ltd (1) · IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy (1) · Institut National de la Santé Et de la Recherche Médicale, France (1) · Kadmon Corporation, LLC (1) · London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's (1)
United States (14) · Canada (6) · China (6) · France (6) · Germany (6) · United Kingdom (6) · Australia (5) · Argentina (4) · Italy (4) · Russia (4) · Brazil (3) · Colombia (3) · Japan (3) · South Korea (3) · Spain (3)
Tanzira Zaman, MD (2) · Anish Ambaram, M.D. (1) · Bei He (1) · Benedict Brockway, M.D. (1) · Bhanu Singh, M.D. (1) · Catherina Chang, M.D. (1) · Danielle Antin-Ozerkis, M.D. (1) · Danielle D. Hosmer (1) · David A Schwartz, MD (1) · David A. Schwartz, MD (1) · David Lederer, M.D. (1) · Elizabeth F Krakow, MD,CM, FRCPC (1) · Elizabeth Veitch, M.D. (1)
PMID 26893034, PMID 30055613, PMID 30742809, PMID 30823880, PMID 31319833, PMID 31416769, PMID 31575509, PMID 32325432, PMID 34709814, PMID 34894681, PMID 34969771, PMID 35058236, PMID 35204752, PMID 36580379, PMID 37264374, PMID 38484130, PMID 38762797, PMID 39362770, PMID 39393084, PMID 39558302, PMID 39879227, PMID 40101437, PMID 40210090, PMID 40355288, PMID 42681624
2016 (1), 2019 (1), R01HL097163 (1), RC1HL099571 (1)